Laxxon Medical to Attend 27th Annual Needham Growth Conference

Laxxon Medical, a prominent pharma-technology firm, will participate in the 27th Annual Needham Growth Conference from January 9-17, 2024. The company's CEO, Helmut Kerschbaumer, and Chief Strategy Officer, Alexander Ruckdaeschel, will engage in one-on-one meetings with investors from institutional, private equity, and venture capital sectors.

The conference represents a significant opportunity for Laxxon Medical to foster connections with potential investors. Interested parties can contact their Needham representative to arrange meetings with the company.

Laxxon Medical is recognized for its pioneering work in smart drug delivery systems, particularly through its SPID®-Technology, which optimizes drug delivery and enhances patient success. The company's IP portfolio consists of over 230 patents and applications.